Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
Clinical trial NCT05996627 · RECRUITING
Trial details
- NCT number
- NCT05996627
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2028-04-30
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.